Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald B Kohn

Showing results (131-140 of 273) with videos related to

Pageof 28
Sort By:
Blood|March 22, 2008
Neonatal bone marrow transplantation of ADA-deficient SCID mice results in immunologic reconstitution despite low levels of engraftment and an absence of selective donor T lymphoid expansionDenise A Carbonaro, Xiangyang Jin, Daniel Cotoi, et al.
Journal of Pediatric Hematology/Oncology|June 6, 2008
Progressive declines in neurocognitive function among survivors of hematopoietic stem cell transplantation for pediatric hematologic malignanciesAmi J Shah, Karen Epport, Colleen Azen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 2, 2012
Nonmyeloablative conditioning regimen to increase engraftment of gene-modified hematopoietic stem cells in young rhesus monkeysAlice F Tarantal, Francesca Giannoni, C Chang I Lee, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 13, 2020
Busulfan Pharmacokinetics in Adenosine Deaminase-Deficient Severe Combined Immunodeficiency Gene TherapyKathryn L Bradford, Siyu Liu, Maja Krajinovic, et al.
Journal of Clinical Immunology|September 4, 2020
Adenosine Deaminase (ADA)-Deficient Severe Combined Immune Deficiency (SCID) in the US Immunodeficiency Network (USIDNet) RegistryCaroline Y Kuo, Elizabeth Garabedian, Jennifer Puck, et al.
ACS Applied Materials & Interfaces|August 24, 2023
Fluorinated Silane-Modified Filtroporation Devices Enable Gene Knockout in Human Hematopoietic Stem and Progenitor CellsIsaura M Frost, Alexandra M Mendoza, Tzu-Ting Chiou, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 14, 2014
Effects of vector backbone and pseudotype on lentiviral vector-mediated gene transfer: studies in infant ADA-deficient mice and rhesus monkeysDenise Carbonaro Sarracino, Alice F Tarantal, C Chang I Lee, et al.
Blood|July 27, 2012
Gene therapy/bone marrow transplantation in ADA-deficient mice: roles of enzyme-replacement therapy and cytoreductionDenise A Carbonaro, Xiangyang Jin, Xingchao Wang, et al.
Nature Biotechnology|July 6, 2010
Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivoNathalia Holt, Jianbin Wang, Kenneth Kim, et al.
Transplantation|June 18, 2004
Use of lentiviral vectors to induce long-term tolerance to gal(+) heart graftsMary Kearns-Jonker, Jacqueline Fischer-Lougheed, Irina Shulkin, et al.
Pageof 28

Showing results (131-140 of 273) with videos related to

Sort By:
Pageof 28
Blood|March 22, 2008
Neonatal bone marrow transplantation of ADA-deficient SCID mice results in immunologic reconstitution despite low levels of engraftment and an absence of selective donor T lymphoid expansionDenise A Carbonaro, Xiangyang Jin, Daniel Cotoi, et al.
Journal of Pediatric Hematology/Oncology|June 6, 2008
Progressive declines in neurocognitive function among survivors of hematopoietic stem cell transplantation for pediatric hematologic malignanciesAmi J Shah, Karen Epport, Colleen Azen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 2, 2012
Nonmyeloablative conditioning regimen to increase engraftment of gene-modified hematopoietic stem cells in young rhesus monkeysAlice F Tarantal, Francesca Giannoni, C Chang I Lee, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 13, 2020
Busulfan Pharmacokinetics in Adenosine Deaminase-Deficient Severe Combined Immunodeficiency Gene TherapyKathryn L Bradford, Siyu Liu, Maja Krajinovic, et al.
Journal of Clinical Immunology|September 4, 2020
Adenosine Deaminase (ADA)-Deficient Severe Combined Immune Deficiency (SCID) in the US Immunodeficiency Network (USIDNet) RegistryCaroline Y Kuo, Elizabeth Garabedian, Jennifer Puck, et al.
ACS Applied Materials & Interfaces|August 24, 2023
Fluorinated Silane-Modified Filtroporation Devices Enable Gene Knockout in Human Hematopoietic Stem and Progenitor CellsIsaura M Frost, Alexandra M Mendoza, Tzu-Ting Chiou, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 14, 2014
Effects of vector backbone and pseudotype on lentiviral vector-mediated gene transfer: studies in infant ADA-deficient mice and rhesus monkeysDenise Carbonaro Sarracino, Alice F Tarantal, C Chang I Lee, et al.
Blood|July 27, 2012
Gene therapy/bone marrow transplantation in ADA-deficient mice: roles of enzyme-replacement therapy and cytoreductionDenise A Carbonaro, Xiangyang Jin, Xingchao Wang, et al.
Nature Biotechnology|July 6, 2010
Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivoNathalia Holt, Jianbin Wang, Kenneth Kim, et al.
Transplantation|June 18, 2004
Use of lentiviral vectors to induce long-term tolerance to gal(+) heart graftsMary Kearns-Jonker, Jacqueline Fischer-Lougheed, Irina Shulkin, et al.
Pageof 28